Printer Friendly

IMCERA SHARE REPURCHASE RESUMED

 IMCERA SHARE REPURCHASE RESUMED
 NORTHBROOK, Ill., Feb. 20 /PRNewswire/ -- IMCERA Group Inc.


(NYSE: IMA) announced today that it has resumed repurchase of its common stock on the open market, as part of its stock repurchase authorization.
 "Purchase of our own stock is one of the various investment opportunities to which we give continuing attention," said M. Blake Ingle, IMCERA president and chief operating officer. "Repurchase at this time reaffirms our belief in the long-term prospects of the company, and it will enhance shareholder value."
 IMCERA's board of directors reinstated IMCERA's repurchase authorization program last October. It had been suspended last April due to a common stock equity offering that was completed last year. There are currently 14.4 million shares remaining in the repurchase authorization.
 A Fortune 300 company with net sales of more than $1.6 billion in fiscal 1991, IMCERA provides human and animal health care products and specialty chemicals through its three international, technology-based businesses -- Mallinckrodt Medical of St. Louis; Mallinckrodt Specialty Chemicals of Chesterfield, Missouri; and Pitman-Moore of Lake Forest, Ill.
 -0- 2/20/92
 /CONTACT: Dave Prichard of IMCERA, 708-205-2270/
 (IMA) CO: IMCERA Group Inc. ST: Illinois IN: CHM SU:


KD -- NY094 -- 1149 02/20/92 17:24 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 20, 1992
Words:204
Previous Article:UNIVERSAL INTERNATIONAL ANNOUNCES FOURTH QUARTER RECORD REVENUES AND EARNINGS; ANNUAL RECORDS ARE ALSO SET IN 1991
Next Article:INDUSTRY URGES VRA EXTENSION FOR SPECIALTY STEEL
Topics:


Related Articles
IMCERA'S MALLINCKRODT SPECIALTY CHEMICALS UNIT SELLS VAN DYK COSMETIC CHEMICALS BUSINESS TO INTERNATIONAL SPECIALTY PRODUCTS
IMCERA'S BOARD OF DIRECTORS SETS 1992 ANNUAL MEETING DATE
IMCERA REPORTS INCREASE IN PER-SHARE EARNINGS FROM CONTINUING OPERATIONS OF 12 PERCENT IN SECOND QUARTER
IMCERA REPORTS 7 PERCENT DECREASE IN PER-SHARE EARNINGS FROM CONTINUING OPERATIONS IN 3RD QUARTER, REVIEWS PROGRAM TO IMPROVE PITMAN-MOORE
IMCERA'S BOARD OF DIRECTORS DECLARES QUARTERLY DIVIDENDS
IMCERA COMPLETES RESTRUCTURING PROGRAM; EXPECTS FOURTH QUARTER PRETAX RESTRUCTURING CHARGE; ADOPTS FASB STANDARDS 106, 109 AND 112
IMCERA'S BOARD OF DIRECTORS SETS 1993 ANNUAL MEETING DATE
IMCERA REPORTS EARNINGS PER SHARE FROM CONTINUING OPERATIONS OF $1.65 FOR FISCAL 1993, BEFORE RESTRUCTURING CHARGES
MALLINCKRODT'S BOARD OF DIRECTORS DECLARES QUARTERLY DIVIDENDS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters